Publication:
Sustained circulation of enterovirus D68 in Europe in 2023 and the continued evolution of enterovirus D68 B3-lineages associated with distinct amino acid substitutions in VP1 protein.

dc.contributor.authorHirvonen, Aurora
dc.contributor.authorJohannesen, Caroline Klint
dc.contributor.authorSimmonds, Peter
dc.contributor.authorFischer, Thea K
dc.contributor.authorHarvala, Heli
dc.contributor.authorBenschop, Kimberley S M
dc.contributor.authorENPEN study collaborators
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERESP (Epidemiología y Salud Pública)
dc.contributor.funderUnión Europea. Comisión Europea. NextGenerationEU
dc.contributor.funderHelsinki University Hospital
dc.contributor.funderThe Slovenian Research and Innovation Agency
dc.contributor.funderRijksinstituut voor Ziekte- en Invaliditeitsverzekering
dc.contributor.reviewerCabrerizo, Maria
dc.contributor.reviewerFernandez-Garcia, Maria Dolores
dc.date.accessioned2026-08-17T15:32:40Z
dc.date.available2026-08-17T15:32:40Z
dc.date.issued2025-06
dc.description.abstractBackground: Enterovirus D68 (EV-D68) causes respiratory disease ranging from mild to severe and in rare cases a paralytic syndrome, called acute flaccid myelitis (AFM). Since the global EV-D68 outbreak in 2014, the virus has mainly circulated in biennial epidemic cycles with peaks detected during even years. However, following the COVID-19 pandemic, the seasonal pattern of EV-D68 has been characterized by large yearly upsurges. Here, we describe the circulation of EV-D68 in Europe in 2023 and track its genetic evolution. Study design: Data was compiled from members of the European Non-Polio Network (ENPEN). This included monthly data on the total number of EV samples tested, EV positive samples, EV-D68 positive samples and cases, and other EV positive samples detected in 2023. Information on sample types and surveillance system was recorded. Sequence data from the VP1 gene was used for phylogenetic and amino acid sequence analysis. Results: EV was detected in 13,585 out of 203,622 diagnostic samples tested (6.7 %), of which 402 (3.0 %) were determined as EV-D68, representing 386 cases. EV-D68 infections peaked in October 2023 (136/386; 35.2 %). 267/386 (69.2 %) of EV-D68 cases were captured through clinical EV surveillance, almost all of which (202/204 of positive samples with sample type information) were detected in respiratory specimens. Phylogenetic analysis performed on 99 VP1 sequences revealed a distinct B3-derived lineage with a previously undescribed residue change, D554E, in Europe. Conclusions: The study documents sustained circulation of EV-D68 in Europe in 2023, the evolution of B3-derived lineages, and appearance of previously undescribed amino acid substitutions in Europe. This stresses the need for continuous EV-D68 surveillance and harmonization of EV-D68 detection practices towards better data comparability across countries.
dc.description.peerreviewed
dc.description.sponsorshipThis work was supported by Fondo de Investigación Sanitaria, Ministerio Español de Economía y Competitividad (grant FIS PI22/00023; ES01); Instituto de Salud Carlos III (grant PI22CIII/00035; ES05); Foundation of Influenza Epidemiology (FIE; ES06); CIBERESP Network of Excellence (ES06); EU funding within the NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007, INF-ACT; IT01); HUS Diagnostic Center (grant TYH2023102 and TYH2024104; FI03); the Czech National Reference Laboratory for Enteroviruses (CZ01); Slovenian Research and Innovation Agency (grant number P3-0083; SI02A); the Ministry of Health of the Republic of Slovenia as part of the National programme for the surveillance of influenza-like illness and acute respiratory infections in Slovenia (SI01). UZ Leuven (BE02), as national reference centre for enteroviruses, was supported by RIZIV-INAMI through the public health institute Sciensano, which is gratefully acknowledged.
dc.format.page105785
dc.format.volume178
dc.identifier.citationHirvonen A, Johannesen CK, Simmonds P, Fischer TK, Harvala H, Benschop KSM; ENPEN study collaborators. Sustained circulation of enterovirus D68 in Europe in 2023 and the continued evolution of enterovirus D68 B3-lineages associated with distinct amino acid substitutions in VP1 protein. J Clin Virol. 2025 Jun;178:105785. doi: 10.1016/j.jcv.2025.105785. Epub 2025 Apr 5. PMID: 40215651.
dc.identifier.doi10.1016/j.jcv.2025.105785
dc.identifier.journalJournal of Clinical Virology
dc.identifier.pubmedID40215651
dc.identifier.urihttps://hdl.handle.net/20.500.12105/27664
dc.language.isoeng
dc.publisherElsevier
dc.relation.projectIDinfo:eu-repo/grantAgreement/EU/NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases/PE00000007///
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/AESI/PI22CIII%2F00035//Investigación de las infecciones por enterovirus que causan enfermedades neurológicas y respiratorias graves en niños. Vigilancia molecular y serológica de los tipos emergentes/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica, Técnica y de Innovación 2021-2023/PI22%2F00023/ES/Sistema integral para la vigilancia clínica, epidemiológica y microbiológica (SiVEV%2FBCN) de la enfermedad asociada a enterovirus en Barcelona ciudad/
dc.relation.projectIDinfo:eu-repo/grantAgreement/HUS Diagnostic Center//TYH2023102///
dc.relation.projectIDinfo:eu-repo/grantAgreement/HUS Diagnostic Center//TYH2024104///
dc.relation.projectIDinfo:eu-repo/grantAgreement/Slovenian Research and Innovation Agency//P3-0083///
dc.relation.publisherversionhttps://doi.org/10.1016/j.jcv.2025.105785
dc.repisalud.centroISCIII::Centro Nacional de Microbiología (CNM)
dc.repisalud.institucionISCIII
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectB3-derived lineages
dc.subjectEnterovirus D68 (EV-D68)
dc.subjectEpidemiology
dc.subjectEurope
dc.subjectSurveillance
dc.subject.meshAmino Acid Substitution
dc.subject.meshCOVID-19
dc.subject.meshCapsid Proteins
dc.subject.meshEnterovirus D, Human
dc.subject.meshEnterovirus Infections
dc.subject.meshEurope
dc.subject.meshEvolution, Molecular
dc.subject.meshHumans
dc.subject.meshPhylogeny
dc.titleSustained circulation of enterovirus D68 in Europe in 2023 and the continued evolution of enterovirus D68 B3-lineages associated with distinct amino acid substitutions in VP1 protein.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication4732254a-afa9-4d9b-8756-8745a4b43003
relation.isFunderOfPublication54f29c6e-1163-4239-8d1d-a0f297ca06e6
relation.isFunderOfPublication7bdd1ec0-e8f6-4fc5-a26b-3e867f6984b3
relation.isFunderOfPublicationfd3dc576-f214-4536-8c10-701fd1fb5100
relation.isFunderOfPublication0d9ed20e-fd9d-40e1-b2fd-3b37240fc4dd
relation.isFunderOfPublication.latestForDiscovery7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isPublisherOfPublication7d471502-7bd5-4f7a-90a4-8274382509ef
relation.isPublisherOfPublication.latestForDiscovery7d471502-7bd5-4f7a-90a4-8274382509ef
relation.isReviewerOfPublication9d46c24b-57af-4d1f-9df2-67ce5c248b37
relation.isReviewerOfPublicationc3d82c4d-2ba9-4976-9d55-ce331622056f
relation.isReviewerOfPublication.latestForDiscovery9d46c24b-57af-4d1f-9df2-67ce5c248b37

Files

Original bundle

Now showing 1 - 3 of 3
Loading...
Thumbnail Image
Name:
SustainedCirculationEnterovirusD68_2025.pdf
Size:
2.88 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Supplementary_SustainedCirculationEnterovirusD68_2025.docx
Size:
42.97 KB
Format:
Microsoft Word XML
Loading...
Thumbnail Image
Name:
Figures_SustainedCirculationEnterovirusD68_2025.zip
Size:
401.02 KB
Format: